Back Bay makes deal with Nor­way's DNB in bank­ing and ad­vi­so­ry part­ner­ship

The Nor­we­gian in­vest­ment bank DNB will take a “mean­ing­ful mi­nor­i­ty stake” in Back Bay Life Sci­ence Ad­vi­sors in a part­ner­ship that Back Bay says will help both com­pa­nies ex­pand their of­fer­ings to biotech and phar­ma.

Back Bay of­fers ad­vi­so­ry and in­vest­ment bank­ing ser­vices, and the part­ner­ship will help it get in­volved in big­ger trans­ac­tions that the bou­tique firm might have pre­vi­ous­ly seen pass on to oth­er ad­vi­sors. The com­pa­ny, which has about 30 staffers, is based in Boston and has been in­volved in a long list of li­cens­ing and pipeline deals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER